Health Canada vs NHRA: Medical Device Regulatory Comparison
Compare the medical device registration pathways, classification, and regulatory requirements of Health Canada (Canada) vs NHRA (Bahrain).
Health Canada
Health Canada — Therapeutic Products Directorate
Canada
Health Canada regulates medical devices through a four-class risk-based system. Class I devices require an establishment license, while Class II-IV require pre-market review. Canada is an MDSAP partic…
Class I, II, III, IV
MDEL (Class I), MDL (Class II-IV)
- ▸Medical Device License (MDL)
- ▸MDSAP single audit program
- ▸Incident reporting via MEDDEV
- ▸Medical Device Establishment License (MDEL)
NHRA
NHRA — Bahrain Medical Device Regulatory Authority
Bahrain
NHRA is the national regulatory authority responsible for medical device oversight in Bahrain. It manages device registration, market surveillance, and adverse event reporting within the Middle East r…
Class A, B, C, D
NHRA registration
- ▸Device registration
- ▸Market surveillance
- ▸Adverse event reporting
- ▸Import/export control
MedFlux monitors both Health Canada and NHRA in real time — every regulatory change, safety alert, and market signal delivered in under 90 seconds.
COMPARE LIVE DATA FREE →